PROCEPT BioRobotics Corp
PRCT- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001588978
In the last 90 days, PROCEPT BioRobotics Corp insiders filed 1 open-market purchase and 3 sales; 253 institutions reported holding it in 13F filings for Q2 2026, worth $1.24B in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in PROCEPT BioRobotics Corp as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 281
- +35 vs. Q3 2024
- Shares held
- 50.3M
- +4.61M (+10.1%) vs. Q3 2024
- Total value
- $4.06B
- +$403.5M (+11.1%) vs. Q3 2024
- New holders
- 66
- 116 more added
- Sold out
- 31
- 77 more reduced
4 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PRCT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 253 | $1.24B |
| Q1 2026 | 257 | $1.40B |
| Q4 2025 | 263 | $1.77B |
| Q3 2025 | 242 | $2.06B |
| Q2 2025 | 271 | $3.07B |
| Q1 2025 | 279 | $2.94B |
| Q4 2024 | 281 | $4.06B |
| Q3 2024 | 250 | $3.65B |
| Q2 2024 | 202 | $2.69B |
| Q1 2024 | 162 | $2.26B |
| Q4 2023 | 145 | $1.91B |
| Q3 2023 | 127 | $1.46B |
| Q2 2023 | 120 | $1.27B |
| Q1 2023 | 116 | $937.6M |
| Q4 2022 | 116 | $1.36B |
| Q3 2022 | 104 | $1.40B |
| Q2 2022 | 96 | $1.14B |
| Q1 2022 | 58 | $1.08B |
| Q4 2021 | 60 | $732.3M |
| Q3 2021 | 58 | $1.03B |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding PROCEPT BioRobotics Corp; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −2,896−100.0% | Sold out |
| Neo Ivy Capital Management | 0 | $0 | 0.00% | −2,838−100.0% | Sold out |
| Gotham Asset Management, LLC | 0 | $0 | 0.00% | −2,843−100.0% | Sold out |
| Canton Hathaway, LLC | 0 | $0 | 0.00% | −820−100.0% | Sold out |
| Harvest Fund Management Co., Ltd | 0 | $0 | 0.00% | −725−100.0% | Sold out |
| Values First Advisors, Inc. | 0 | $0 | 0.00% | −343−100.0% | Sold out |
| NBC Securities, Inc. | 0 | $0 | 0.00% | −204−100.0% | Sold out |
| Venturi Wealth Management, LLC | 0 | $0 | 0.00% | −60−100.0% | Sold out |
| Manchester Capital Management LLC | 0 | $0 | 0.00% | −37−100.0% | Sold out |
| Reuter James Wealth Management, LLC | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| Capital Performance Advisors LLP | 0 | $0 | 0.00% | −16−100.0% | Sold out |
| Quest Partners LLC | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Raymond James & Associates | – | – | – | – | Not filed |
| SpiderRock Advisors, LLC | – | – | – | – | Not filed |
| PEAK6 Investments LLC | – | – | – | – | Not filed |
| Raymond James Financial Services Advisors, Inc. | – | – | – | – | Not filed |